Postoperative Pain Management of Caesarean Section: a Prospective, Observational Cohort Study

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Drug
Study Type: Observational
SUMMARY

Caesarean section is one of the most frequent surgeries causing severe postoperative pain. Poor management of acute pain can contribute to postoperative complications, late recovery and the development of chronic pain. Moreover, it had been demonstrated that the intensity of postpartum pain is associated with depression. It is imperative to find out appropriate methods of postpartum pain alleviation. Currently, a lot of analgesic drugs and methods have been developed and used in clinical practice, such as patient-controlled analgesia, extended-release analgesics and multimodal analgesia. This prospective cohort study is aimed to investigate the outcome of each postoperative analgesic method used in caesarean section.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 20
Maximum Age: 40
Healthy Volunteers: f
View:

• Aged 20 to 40.

• Planing to undergo caesarean section with spinal anesthesia.

• Scheduled to undergo cesarean section between 37 and 40 weeks of gestation.

• American Society of Anesthesiology Physical Class 1-2.

• Planing to alleviate postoperative pain with intravenous patient-controlled analgesia or administration of NALDEBAIN.

Locations
Other Locations
Taiwan
MacKay Memorial Hospital Tamsui Branch
RECRUITING
New Taipei City
MacKay Memorial Hospital
NOT_YET_RECRUITING
Taipei
Contact Information
Primary
Chi-Hsu Wang, M.D.
s871017@gmail.com
+886-2-2809-4661
Time Frame
Start Date: 2022-02-23
Estimated Completion Date: 2026-07-31
Participants
Target number of participants: 100
Treatments
IV-PCA + NALDEBAIN group
Patients treated with the combination of IV-PCA and intramuscular injection of dinalbuphine sebacate will be allocated to IV-PCA + NALDEBAIN group.
IV-PCA group
Patients receiving intravenous patient-controlled analgesia (IV-PCA) will be allocated to IV-PCA group.
Related Therapeutic Areas
Sponsors
Leads: Mackay Memorial Hospital

This content was sourced from clinicaltrials.gov